A Phase 1/1b Open-Label Multi-Center Study to Characterize the Safety and Tolerability of TRQ15-01 in Patients With Relapsed/Refractory Solid Tumors and Lymphomas
What is the purpose of this trial?
The purpose of this study is to assess the safety and tolerability of escalating doses of TRQ15-01 in patients with relapsed/refractory/metastatic or locally-advanced solid tumors and lymphomas.
- Trial withTorque Therapeutics
- Start Date05/02/2019
- End Date08/31/2021
- Last Updated05/06/2019
- Study HIC#2000024303